PMID- 31319160 OWN - NLM STAT- MEDLINE DCOM- 20200430 LR - 20200430 IS - 1096-1194 (Electronic) IS - 0890-8508 (Linking) VI - 46 DP - 2019 Aug TI - Evaluation of two aneuploidy screening tests for chorionic villus samples: Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. PG - 101422 LID - S0890-8508(19)30201-4 [pii] LID - 10.1016/j.mcp.2019.101422 [doi] AB - The vast majority of first-trimester pregnancy losses are the consequence of numerical aberrations in fetal chromosomes, which may involve nearly all chromosomes. Although commercial probes for all chromosomes are available for multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) analyses, their use has rarely been reported for screening all 24 chromosomes for early fetal demise, especially by FISH. Here, we validated the ability of MLPA and FISH techniques as two low-cost aneuploidy screening methods for 24 chromosomes in 165 chorionic villus samples (CVSs). The results obtained by two methods were compared by the Chi-square test and the Kappa agreement test. Both methods gave conclusive results for all CVSs tested and showed highly consistent results (kappa = 0.890, p < 0.001). There was no statistically significant difference between the aneuploidy rate of the CVSs tested by the two methods (p = 0.180). Most of the samples showed fully concordant molecular karyotyping results (81.21%) between the two analytical methods, 10.91% had incompletely concordant results, and 7.88% had discordant results. The inconsistencies included segmental abnormalities, mosaicism, and polyploidy. Both assays used to screen 24 chromosomes were powerful techniques for detecting aneuploidy in CVSs. In terms of cost-effectiveness and diagnostic accuracy, the combination of subtelomeric (P036, P070) and centromeric (P181) MLPA assays is the better analytic strategy and follow-up analysis by FISH is recommended for MLPA-negative samples. CI - Copyright (c) 2019 Elsevier Ltd. All rights reserved. FAU - Wu, Tonghua AU - Wu T AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Zhu, Yuanchang AU - Zhu Y AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Hong, Ling AU - Hong L AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Lin, Qi AU - Lin Q AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Chen, Chunmei AU - Chen C AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Yang, Jing AU - Yang J AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Ye, Lijun AU - Ye L AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Huang, Wensi AU - Huang W AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. FAU - Zeng, Yong AU - Zeng Y AD - Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, Guangdong, 518045, China. Electronic address: zengyong1966@sina.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190715 PL - England TA - Mol Cell Probes JT - Molecular and cellular probes JID - 8709751 SB - IM MH - *Aneuploidy MH - Chorionic Villi/*physiopathology MH - Chorionic Villi Sampling/*methods MH - Cytogenetic Analysis MH - Female MH - Humans MH - *In Situ Hybridization, Fluorescence MH - Mosaicism MH - Multiplex Polymerase Chain Reaction MH - Pregnancy OTO - NOTNLM OT - Fetal chromosomal abnormality OT - Fluorescence in situ hybridization (FISH) OT - Mosaicism OT - Multiplex ligation-dependent probe amplification (MLPA) OT - Pregnancy loss EDAT- 2019/07/19 06:00 MHDA- 2020/05/01 06:00 CRDT- 2019/07/19 06:00 PHST- 2019/05/26 00:00 [received] PHST- 2019/07/09 00:00 [revised] PHST- 2019/07/15 00:00 [accepted] PHST- 2019/07/19 06:00 [pubmed] PHST- 2020/05/01 06:00 [medline] PHST- 2019/07/19 06:00 [entrez] AID - S0890-8508(19)30201-4 [pii] AID - 10.1016/j.mcp.2019.101422 [doi] PST - ppublish SO - Mol Cell Probes. 2019 Aug;46:101422. doi: 10.1016/j.mcp.2019.101422. Epub 2019 Jul 15.